France vs Timor-Leste: Previously treated cases tested for RR-/MDR-TB
France
4.2%
in 2024
Timor-Leste
0.0%
in 2024
France rank
170th
Timor-Leste rank
173rd
Previously treated cases tested for RR-/MDR-TB over time
- France
- Timor-Leste
How they compare
France currently reports 4.2% against 0.0% in Timor-Leste, a difference of 4.2%.
Across all 12 years both countries report, France has been ahead every year.
France ranks 170th and Timor-Leste ranks 173rd of 180 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.5% | 19.0% | 9.5% | France |
| 2010s | 88.4% | 42.6% | 45.8% | France |
| 2020s | 7.8% | 0.4% | 7.4% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, France or Timor-Leste?
- France, at 4.2% against 0.0% in Timor-Leste as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between France and Timor-Leste?
- 4.2%, with France ahead.
- How many years of comparable data are there for France and Timor-Leste?
- 12 years are reported by both, from 2008 to 2024.
- How do France and Timor-Leste rank globally for previously treated cases tested for rr-/mdr-tb?
- France ranks 170th and Timor-Leste ranks 173rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.